Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fractyl Health

0.9727
-0.0373-3.69%
Post-market: 0.9700-0.0027-0.28%19:59 EDT
Volume:1.97M
Turnover:1.92M
Market Cap:47.64M
PE:-0.53
High:1.05
Open:1.00
Low:0.9300
Close:1.01
52wk High:3.72
52wk Low:0.8250
Shares:48.98M
Float Shares:18.16M
Volume Ratio:0.70
T/O Rate:10.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8440
EPS(LYR):-1.6176
ROE:-196.81%
ROA:-49.05%
PB:7.47
PE(LYR):-0.60

Loading ...

Fractyl Health Raises $20.7M Through Stock Offering

TIPRANKS
·
4 hours ago

Fractyl Health Secures $20.7M in Underwritten Offering to Advance Revita and Rejuva Programs

Reuters
·
5 hours ago

Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares

GlobeNewswire
·
7 hours ago

Fractyl Health Inc. to Report Second Quarter 2025 Financial Results

Reuters
·
Yesterday

BUZZ-U.S. STOCKS ON THE MOVE-Novavax, copper miners, Apple

Reuters
·
Yesterday

Top Midday Decliners

MT Newswires Live
·
Yesterday

Nasdaq Surges 1%; Uber Sales Top Estimates

Benzinga
·
Yesterday

US Stocks Edge Higher; McDonald's Posts Upbeat Earnings

Benzinga
·
Aug 06

BRIEF-Fractyl Health Announces Pricing Of $20 Million Underwritten Public Offering

Reuters
·
Aug 06

Fractyl Health prices 19.05M shares at $1.05 in underwritten public offering

TIPRANKS
·
Aug 06

BUZZ-U.S. STOCKS ON THE MOVE-McDonald's, Coinbase, Super Micro Computer

Reuters
·
Aug 06

BUZZ-Fractyl Health plunges after launching stock offering

Reuters
·
Aug 06

Fractyl Health announces two-year follow-up data from Revita study

TIPRANKS
·
Aug 06

Fractyl Health Inc. Announces Proposed Public Offering of Common Stock and Warrants to Support Pipeline Programs

Reuters
·
Aug 06

Fractyl Health Inc - Pre-Funded Warrant Price Set at Share Price Minus $0.00001

THOMSON REUTERS
·
Aug 06

Fractyl Health Inc - Proceeds to Support Revita and Rejuva Programs

THOMSON REUTERS
·
Aug 06

Fractyl Health Announces Proposed Public Offering

GlobeNewswire
·
Aug 06

Fractyl Health Announces Promising Two-Year Real-World Outcomes for Revita® with Sustained Weight Loss and Improved Glucose Control in Type 2 Diabetes Patients

Reuters
·
Aug 06

Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes With Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure

THOMSON REUTERS
·
Aug 06

Fractyl Health, Inc.: Promising Market Opportunities and Positive Outlook Justify Buy Rating

TIPRANKS
·
Jul 18